VMP 45270811000001109

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Sitagliptin 50mg / Metformin 850mg tablets
BNF code 0601023ADAAABAB
Virtual Therapeutic Moiety Sitagliptin + Metformin
Basis of preferred name Other
Date of name applicability 1 Oct 2025
Previous name Metformin 850mg / Sitagliptin 50mg tablets
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Metformin hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 850.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Sitagliptin
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Sitagliptin 50mg / Metformin 850mg tablets (Alliance Healthcare (Distribution) Ltd)
Sitagliptin 50mg / Metformin 850mg tablets (Macleods Pharma UK Ltd)
Virtual Medicinal Product Packs
Sitagliptin 50mg / Metformin 850mg tablets 56 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.1.0_20251208000001, imported on 9th December 2025 at 04:06:46.

Feedback